Cathy Tie
Cathy Tie
Serial biotech entrepreneur · Founder & CEO, Origin Genomics · Founder, Locke Bio & Ranomics · Thiel Fellow · Former partner, Cervin Ventures · Based in New York
Projects
Ideas brought to life. A look at the products, companies, and creative works built from the ground up.
Origin Genomics
Founded to advance precision germline gene correction and mitochondrial replacement therapy research in the U.S., operating under IRB oversight and emphasizing ethical/regulatory frameworks.
Manhattan Genomics
Company focused on germline genome editing research and methods to improve safety and fidelity of embryo editing; received significant media attention and sparked ethical debate.
Los Angeles Project
Stealth project (incorporated 2023) aimed at gene editing in animals (publicized goals included novel/‘glow-in-the-dark’ edits); positioned as exploratory R&D in embryo editing for animals.
Locke Bio
Digital health / telemedicine platform described as a 'Shopify for healthcare' enabling brands to launch integrated telehealth + pharmacy services; built enterprise product and went to market with clients.
Ranomics
Early genomics startup (founded while a university student) focused on variant screening and functional characterization of genetic variants; participated in IndieBio accelerator and raised early funding.
In the Spotlight
A collection of articles, interviews, and viral content where achievements have been shared.
Recognitions
Formal validation from the top. A showcase of official awards, grants, and government acknowledgements.
Thiel Fellowship
2015Selected as a Thiel Fellow; received a grant to pursue startup work in biotechnology instead of a traditional university path.
Forbes 30 Under 30 (Healthcare)
2018Named to Forbes 30 Under 30 for contributions as a young biotech entrepreneur and founder of Ranomics.
Faces of Impact 100 Honoree
2024-2025Recognized as an honoree for innovation and impact (profile highlights leadership in biotech and digital health).
Work Experience
Key roles that defined the journey.
Founder & CEO
Leading a New York–based company focused on precision germline gene correction research and the ethical/regulatory frameworks required for responsible progress.
Founder & CEO
Built and led a platform enabling brands and organizations to launch integrated telehealth and pharmacy services; positioned as a commerce platform for healthcare.
Founder / Co-founder
Co-founded a genomics screening company focused on characterizing rare variants; participated in IndieBio accelerator and raised early funding.
Partner (Venture Partner)
Served as a young venture partner at Cervin Ventures, providing sourcing and investment support in early-stage technology and biotech.
Founder / Lead
Led efforts to explore human embryo gene correction research and safety testing; generated widespread media and ethical attention.
Membership
Affiliations and memberships in prestigious organizations and communities.
Recipient of the fellowship supporting early-stage founders who leave college to build startups.
Ranomics participated in IndieBio and received accelerator support and early seed funding.
Youngest partner to join the firm; role included investing and advising early-stage companies.
Public LinkedIn post indicates induction to the Board of Directors of the Cold Spring Harbor Labs Association.
Education
Academic foundation and learning journey.
Undergraduate studies (left to pursue entrepreneurship via Thiel Fellowship)
Enrolled at Trinity College (U of Toronto) and worked in research labs before deferring to accept the Thiel Fellowship and pursue Ranomics.
High School (IB Diploma Program)
Attended IB program; early interests in biology and published research as a teenager.
Socials
Connect and explore.